Our Faculty

Scott R. Beach, M.D.

Scott R. Beach, M.D.

Massachusetts General Hospital
 

Biography

Scott R. Beach, M.D., is an Associate Professor of Psychiatry at Harvard Medical School (HMS) and former Program Director for the Massachusetts General Hospital (MGH)/McLean Hospital Adult Psychiatry Residency. He received his undergraduate and medical degrees from the University of Virginia (UVA). He remained at UVA to complete his psychiatry residency before completing a Consultation-Liaison Psychiatry Fellowship at MGH and pursuing a Dupont-Warren Research Fellowship as part of the MGH Cardiac Psychiatry Research Program (CPRP). Clinically, Dr. Beach has worked as an attending physician in the psychiatric emergency room and on inpatient consultation services since 2011. Areas of clinical expertise include QT prolongation with psychiatric medications, catatonia and related syndromes, neuropsychiatric effects of COVID-19, and patients who deceive providers.

Within the realm of education and administration, he served as Co-Site Director for the HMS Psych 700 Introduction to Psychopathology Course for several years, and was a member of the HMS Admissions Committee from 2012-2017. He also served as Co-Director of the Department’s Grand Rounds Committee from 2015-2018, and has won numerous teaching awards from medical students and residents.

From a research standpoint, Dr. Beach has continued his work with the CPRP, focusing on collaborative care models in patients with heart disease, positive emotions and their predictive value following acute coronary syndromes, and QT prolongation with antidepressants. He has been a co-investigator on grants from the National Institute for Health and the American Foundation for Suicide Prevention. He is the author of over 50 peer-reviewed articles and book chapters.

Publications of Scott R. Beach, M.D.

[FR] Quick Take Vol. 83

0.75 CMEs
When should you consider high-dose olanzapine instead of clozapine for treatment-resistant schizophrenia? How effective is aripiprazole augmentation versus switching strategies in older adults with depression? Can GLP-1 receptor agonists elevate lithium levels? Should inflammatory markers guide antidepressant selection? Is adjunctive propranolol effective for panic disorder?
Faculty: James Phelps, M.D., Paul Zarkowski, M.D., Scott R. Beach, M.D., Oliver Freudenreich, M.D., Derick E. Vergne, M.D.
38.56 minutes in 0 audio sections

[FR] Quick Take Vol. 80

0.75 CMEs
How effective is the new antipsychotic KarXT using the number needed to treat metric? Can bright light therapy effectively treat bipolar depression without causing mania? Does IV haloperidol really increase cardiac risks as commonly believed? Can varenicline help reduce alcohol intake in people with alcohol use disorder? Does ashwagandha extract improve cognitive function in mild cognitive impairment?
Faculty: David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M., Scott R. Beach, M.D., Oliver Freudenreich, M.D., Kristin Raj, M.D., Derick E. Vergne, M.D.
39.35 minutes in 5 audio sections

[FR] Quick Take Vol. 79

0.75 CMEs
How should clozapine monitoring change after FDA's REMS removal? Does cariprazine work equally well in older adults with bipolar disorder? Can semaglutide help treat alcohol use disorder? Why do older adults receive subtherapeutic antidepressant doses? Is saffron as effective as SSRIs for depression?
Faculty: David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M., Scott R. Beach, M.D., Oliver Freudenreich, M.D., Kristin Raj, M.D., Derick E. Vergne, M.D.
44.22 minutes in 0 audio sections

Explore our library of over 440 video lectures, podcasts, research summaries and expert interviews.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.